Skip to content
Back to browse
LUNG Publication-derived

Lung Organoids for Infection and Development

Source Chen et al., 2017 · Columbia Center for Human Development, Columbia University Medical Center · 10.1038/ncb3510

Authors: Ya-Wen Chen, Sarah Xuelian Huang, Ana Luisa Rodrigues Toste de Carvalho, Siu-Hong Ho, Mohammad Naimul Islam, Stefano Volpi, Luigi D Notarangelo, Michael Ciancanelli, Jean-Laurent Casanova, Jahar Bhattacharya, Alice F. Liang, Laura M Palermo, Matteo Porotto, Anne Moscona, HansWillem Snoeck Duration: 170 days 7 phases Cell source: Human ESC (RUES2), Human iPSC

Abstract

This protocol describes the generation of three-dimensional lung bud organoids (LBOs) from human pluripotent stem cells that recapitulate lung development through branching airway and early alveolar structures. LBOs can be cultured in vitro in Matrigel or xenotransplanted to model normal lung development and disease states including respiratory syncytial virus infection and fibrotic lung disease.

Cell source
Human ESC (RUES2), Human iPSC
Application
Developmental study, Disease modeling (RSV infection, pulmonary fibrosis)

Protocol overview

23 steps across 7 phases

Phase 1 · hPSC Maintenance and Endoderm Induction Day 0 to Day 4
  1. a hPSC Culture on MEF Feeders
  2. b MEF Depletion
  3. c Primitive Streak and Embryoid Body Induction
  4. d Endoderm Induction
Phase 2 · Anterior Foregut Endoderm (AFE) Specification Day 4 to Day 6
  1. a Dissociation and Plating
  2. b Anteriorization Step 1
  3. c Anteriorization Step 2
Phase 3 · Lung Bud Organoid (LBO) Formation in Suspension Day 6 to Day 20-25
  1. a Ventralization and Clump Formation
  2. b LBO Suspension Culture and Expansion
  3. c LBO Characterization (Optional)
Phase 4 · Matrigel Embedding and Branching Morphogenesis Day 20-25 to Day 70+
  1. a Matrigel Embedding
  2. b Branching Culture Setup
  3. c Branching Morphogenesis Culture
  4. d Long-Term Culture to Day 170+
Phase 5 · Xenotransplantation (Optional) Day 20-25 onwards
  1. a LBO Preparation for Transplantation
  2. b Kidney Capsule Transplantation
Phase 6 · Disease Modeling: RSV Infection Day 170 (or any mature timepoint)
  1. a RSV Preparation
  2. b RSV Infection of LBOs
  3. c RSV Detection and Imaging
Phase 7 · Disease Modeling: HPS1 Pulmonary Fibrosis Day 15 to Day 50+
  1. a Generation of RUES2-HPS1 Cell Line
  2. b LBO Generation from RUES2-HPS1 Cells
  3. c Matrigel Culture and Fibrotic Phenotype Assessment
  4. d Hydroxyproline Measurement

Full SOP

Full SOPs need an account and a plan

Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.

Create an account

Already registered? Log in

Attribution

This SOP was written by Organthis based on the published method in Chen et al., 2017. Once the originating laboratory has confirmed it, the SOP is marked Verified.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.